Related references
Note: Only part of the references are listed.Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports
Adam Goldman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
Benjamin S. Abella et al.
JAMA INTERNAL MEDICINE (2021)
From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
S. Rakedzon et al.
JOURNAL OF TRAVEL MEDICINE (2021)
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Oriol Mitja et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Singapore's Pandemic Preparedness: An Overview of the First Wave of COVID-19
Jia Bin Tan et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR
Lianhua Dong et al.
TALANTA (2021)
Epidemiological and Clinical Predictors of COVID-19
Yinxiaohe Sun et al.
CLINICAL INFECTIOUS DISEASES (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Interrupting transmission of COVID-19: lessons from containment efforts in Singapore
Vernon J. Lee et al.
JOURNAL OF TRAVEL MEDICINE (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease
Danielle E. Anderson et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Markus Hoffmann et al.
NATURE (2020)
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Pauline Maisonnasse et al.
NATURE (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Migrant workers and COVID-19
David Koh
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2020)
In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2
Samantha Frank et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)
Rapid review protocol: Zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections
Jennifer Hunter et al.
INTEGRATIVE MEDICINE RESEARCH (2020)
Coronavirus Disease 2019 (COVID-19): The Singapore Experience. A Review of the First Eight Months
Trevor Hwee Yong Tan et al.
ANNALS ACADEMY OF MEDICINE SINGAPORE (2020)
Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible
Lea A. Nikolai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
Alex Stevenson et al.
OPEN HEART (2020)
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
Aartjan J. W. Te Velthuis et al.
PLOS PATHOGENS (2010)
Share Paper
